Drug major Sun Pharmaceutical Industries Tuesday reported a nearly four-fold jump in its consolidated net profit at Rs 1,241.85 crore for the quarter ended December 31, 2018.
The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
Consolidated revenue from operations of the company stood at Rs 7,740.19 crore for the quarter under consideration as against Rs 6.653.23 crore for the same period year ago.
Shares of Sun Pharmaceutical Industries closed at Rs 436.75 per scrip on BSE, up 2 per cent from their previous close.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.